Related Experiment Video
Updated: May 22, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Coccidioidomycosis: first imported case in Italy
Federico Gobbi1, Andrea Angheben, Claudio Farina
1Centre for Tropical Diseases, Hospital Sacro Cuore-Don Calabria, Negrar, Verone, Italy. federico.gobbi@sacrocuore.it
Pulmonary coccidioidomycosis, a fungal infection from the United States, was diagnosed in Italy. Consider this diagnosis in febrile patients with lung symptoms returning from endemic regions.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pulmonology
Background:
- Coccidioidomycosis is a systemic fungal infection caused by Coccidioides species.
- Endemic areas are primarily in the southwestern United States and parts of Mexico and Central/South America.
- Imported cases highlight the importance of considering endemic diseases in non-endemic regions.
Observation:
- A case of pulmonary coccidioidomycosis was identified in Italy.
- The patient had a history of travel to the United States, an endemic area.
- Clinical presentation included pulmonary symptoms and hypereosinophilia.
Findings:
- The diagnosis of pulmonary coccidioidomycosis was confirmed in the imported case.
- This case underscores the potential for geographic spread of Coccidioides immitis.
- Hypereosinophilia can be a presenting sign of coccidioidomycosis.
Implications:
- Pulmonary coccidioidomycosis should be included in the differential diagnosis for febrile patients with respiratory symptoms returning from endemic areas.
- Increased global travel necessitates awareness of imported infectious diseases.
- Prompt diagnosis and treatment are crucial for managing coccidioidomycosis.
Related Concept Videos
Infectious Diseases and Their Occurrence
Fungal Phylum Microsporidia
Cytomegalovirus Disease
Investigation of Disease Outbreaks
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Encephalitis l: Introduction
